Results for "Centene"

Drew Asher, the Chief Financial Officer of Centene, is set to resign from his position.

Wall Street analysts are providing their predictions on the future trajectory of Centene stock, forecasting whether its value is expected to climb or sink.

Centene has projected its adjusted earnings per share for 2026 to exceed $4.80, with its Marketplace segment targeting a pretax margin of 4.5% to 5%.

Centene Corp. has increased its annual profit guidance after reporting better-than-expected second-quarter results, attributing the positive outlook to favorable medical costs and confidence in navigating policy changes.

Shares of Molina, Centene, and Oscar experienced a downturn following the release of Elevance Health’s second-quarter financial report.

Humana and Centene are leading a rally in the healthcare sector during Q2, driven by growing optimism surrounding Medicare Advantage programs.

Centene, a healthcare company, is offering employee buyouts as it faces a decline in its membership numbers. This move is likely part of a broader strategy to manage costs and restructure operations.

An analysis questions whether Centene (CNC) is among the most undervalued stocks suitable for a two-year buy and hold strategy.

Analysts on Wall Street appear to have mixed opinions regarding the future performance and investment potential of Centene stock.

Investor David Einhorn's firm has reportedly increased its stake or expressed bullish sentiment in several companies, including PG&E, Centene, Capri Holdings, and Fluor Corporation. This indicates a strategic investment move across various sectors.

Centene is the most recent health insurer to undergo a significant shakeup in its management ranks.

UBS has lowered its price target for Southwest Airlines Co. (LUV) from $59 to $56, providing reasons for the revised valuation.

The ongoing challenges and potential decline of Obamacare are reportedly having a debilitating effect on Centene Corporation's stock performance.

Americans are opting out of the Affordable Care Act, and health insurance companies are taking a financial hit.

Multiple financial institutions have updated their price targets and ratings for various companies, reflecting new outlooks on their performance and market conditions.

Analysts are speculating whether Centene (CNC) is on the verge of a major margin recovery, indicating potential positive financial performance for the company.

A summary of Centene Corporation's second-quarter 2026 earnings call provides key financial highlights and business updates from the company.

Centene and Armstrong World both announced robust second-quarter financial results, with Centene reporting non-GAAP EPS of $2.51 and revenue of $53.58 billion, and Armstrong World reporting non-GAAP EPS of $2.36 and revenue of $472 million. Both companies significantly surpassed analyst expectations for both earnings and revenue.

Centene Corporation (CNC) saw its stock rally following the announcement of robust financial results, indicating positive investor reaction to the company's performance.

Centene Corporation has announced the addition of a veteran from JPMorgan to its board of directors. This strategic appointment is expected to bring significant financial and industry expertise to the healthcare enterprise.

Centene (CNC) has been included on Bank of America's list of highest-conviction investment opportunities.

An analysis explores whether Centene Corporation (CNC) stands out as one of the best healthcare stocks for long-term investment.

Seeking Alpha analysts have issued new upgrades and downgrades for several prominent technology stocks, including Amazon, Google, Twilio, and Centene.

Centene has raised its profit guidance for 2026 following a buoyant first-quarter performance, indicating a positive outlook for the healthcare company.

An analysis explores the factors contributing to Centene Corporation's attractive growth outlook.

Centene Corporation has announced the creation of two new executive leadership positions as part of a strategic restructuring within the company.

The Wall Street Journal continues its market news coverage, detailing Campbell's ongoing snack issues, Centene's stock decline, and sustained optimism surrounding Petco, with new reports reinforcing these market trends.

An analysis questions whether Centene stock is underperforming compared to the Nasdaq index, providing insights for investors.

Centene's stock experienced a decline after its CEO attributed the company's performance to challenges related to the Affordable Care Act (Obamacare). The statement highlighted financial pressures impacting the healthcare provider.

Several financial institutions have updated their price targets and ratings for various companies, including Centene, Unity Software, Block, Zillow, DraftKings, Instacart, CoStar, and Occidental Petroleum.

Centene reported a significant turnaround in its Q2 2026 financial results, swinging to a profit of more than $1 billion and indicating it is 'back on track.'

A quant snapshot of the market shows Bandwidth and Centene Corporation as top-rated names, while Bank of Marin Bancorp and Axos Financial Dynamics are lagging.

RBC Capital Markets has initiated coverage on Centene (CNC), expressing a positive outlook and suggesting that the company's challenges from 2025 are now behind it.

An analysis questions whether Centene stock is currently outperforming the Dow Jones Industrial Average.

Artificial intelligence has identified several promising stocks to buy across various sectors, including large-cap consumer discretionary, industrial, and energy companies. Notable mentions include Apple, Microsoft, Nvidia, Centene, Coca-Cola, and Xcel Energy.

Greenlight Capital's David Einhorn presented five "transition stories" or turnaround stock picks at the Sohn Investment Conference. Among his selections were Acadia Healthcare and Centene, spanning sectors from AI to infrastructure.

Investor David Einhorn has expressed a bullish outlook on Centene Corporation (CNC), a managed care firm, indicating a positive investment perspective.

Centene has increased its adjusted EPS outlook for 2026 to greater than $3.40, incorporating an estimated 3% Marketplace pretax margin into its projections.

The transcript for Centene's (CNC) third-quarter 2024 earnings call has been released, detailing the company's financial results.

Expectations are being set for Centene's first-quarter 2026 earnings report, with a focus on the healthcare company's financial performance.

Piper Sandler has lowered its price target for Campbell's (CPB) to $28, citing pressure on the company's sales, which aligns with earlier reports from The Wall Street Journal detailing Campbell's ongoing snack problems.

Centene's stock has fallen following warnings related to the Affordable Care Act, even as it maintains a top 'Buy' Quant rating within the managed care sector.

Centene, a healthcare enterprise, has announced its decision to reaffirm its full-year earnings guidance, providing an update on its financial outlook for investors.